Connection

BORJE S ANDERSSON to Daunorubicin

This is a "connection" page, showing publications BORJE S ANDERSSON has written about Daunorubicin.
Connection Strength

0.419
  1. Doxorubicin- and daunorubicin-induced energy deprivation and nucleotide degradation in isolated cardiomyocytes. Toxicology. 1996 Nov 15; 114(1):1-10.
    View in: PubMed
    Score: 0.132
  2. Significance of cellular pharmacokinetics for the cytotoxic effects of daunorubicin. Cancer Res. 1982 Jan; 42(1):178-83.
    View in: PubMed
    Score: 0.047
  3. Differences in the plasma kinetics of daunorubicin in normal and leukemic rats. Acta Radiol Oncol. 1981; 20(5):325-8.
    View in: PubMed
    Score: 0.044
  4. Leukemic cell versus plasma levels of daunorubicin and daunorubicinol after infusion of daunorubicin as free drug or the DNA complex. Cancer Chemother Pharmacol. 1980; 4(3):205-7.
    View in: PubMed
    Score: 0.041
  5. Uptake and distribution of daunorubicin and daunorubicin-DNA complex in mice as studied by whole-body autoradiography and liquid chromatography. Cancer Chemother Pharmacol. 1979; 2(3):159-67.
    View in: PubMed
    Score: 0.038
  6. Liquid chromatographic monitoring of daunorubicin and daunorubicinol in plasma from leukemic patients treated with daunorubicin or the daunorubicin-DNA complex. Cancer Chemother Pharmacol. 1979; 2(1):15-7.
    View in: PubMed
    Score: 0.038
  7. A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML. Blood. 2017 02 09; 129(6):740-758.
    View in: PubMed
    Score: 0.033
  8. Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of autologous cells. Blood. 1995 Jun 01; 85(11):3257-63.
    View in: PubMed
    Score: 0.015
  9. Pharmacokinetics of daunorubicin after administration as free drug or as DNA complex in leukemic patients. Cancer Chemother Pharmacol. 1981; 5(4):261-6.
    View in: PubMed
    Score: 0.011
  10. Comparative studies on the in vitro killing of human normal and leukemic clonogenic cells (CFUc) by daunorubicin, daunorubicinol, and daunorubicin-DNA complex. Cancer Chemother Pharmacol. 1979; 2(1):19-24.
    View in: PubMed
    Score: 0.010
  11. Liquid chromatographic determination of daunorubicin and daunorubicinol in plasma from leukemic patients. J Chromatogr. 1978 Jun 01; 153(1):211-8.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.